Clinical Research Directory
Browse clinical research sites, groups, and studies.
Drug Discovery for Parkinson's With Mutations in the GBA Gene
Sponsor: New York Stem Cell Foundation Research Institute
Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2022-07-15
Completion Date
2025-07-15
Last Updated
2025-03-03
Healthy Volunteers
Yes
Interventions
Biological Sample Collection
Skin biopsy (2-3mm) and/or blood (up to 50 mL); saliva; excess/leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure)
Locations (1)
The New York Stem Cell Foundation Research Institute
New York, New York, United States